Global Radiopharmaceuticals Market, By Product Type (Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals) and Therapeutic Nuclear Medicine), By Application (Oncology, Cardiology, Neurology, Endocrinology, and Others), By End User (Hospitals, Specialty Clinics, and Diagnostic Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Trend Analysis, Competitive Market Share & Forecast, 2020-2027
Published:
April 2021
Report Code:
bwc20324
Available Format:
PDF PDF Icon
Pages:
178

radiopharmaceuticals market rd

1. Research Framework

    1.1. Research Objective

    1.2. Product Overview

    1.3. Market Segmentation

2. Research Methodology

    2.1. Qualitative Research

            2.1.1. Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

           2.3.1. Secondary Research

           2.3.2. Primary Research

    2.4. Breakdown of Primary Research Respondents, By Region

    2.5. Assumption & Limitation

3. Executive Summary

4. Global Radiopharmaceuticals Market Insights

    4.1. DROC Analysis

           4.1.1. Growth Drivers

           4.1.2. Restraints

           4.1.3. Opportunities

           4.1.4. Challenges

    4.2. Recent Development

    4.3. Porter’s Five Forces Analysis

            4.3.1. Bargaining Power of Suppliers

            4.3.2. Bargaining Power of Buyers

            4.3.3. Threat of New Entrants

            4.3.4. Threat of Substitutes

            4.3.5. Intensity of Rivalry

   4.4 Value Chain Analysis

   4.5 Strategic Outlook

   4.6 Regulatory Framework

   4.7 Key Strategic Developments

5. Global Pharmaceuticals Market Overview

    5.1. Market Size & Forecast by Value, 2020-2027

            5.1.1. By Value (USD Million)

    5.2. Market Share & Forecast

            5.2.1. By Product Type

                5.2.1.1. Diagnostic Nuclear Medicine

                         5.2.1.1.1. SPECT Radiopharmaceuticals

                         5.2.1.1.2. PET Radiopharmaceuticals)

                5.2.1.2. Therapeutic Nuclear Medicine     

            5.2.2. By Application

                5.2.2.1. Oncology

                5.2.2.2. Cardiology

                5.2.2.3. Neurology

                5.2.2.4. Endocrinology

               5.2.2.5. Others

          5.2.3. By End-User

              5.2.3.1. Hospitals

              5.2.3.2. Specialty Clinics

              5.2.3.3. Diagnostic Centers

          5.2.4. By Region

             5.2.4.1. North America

             5.2.4.2. Latin America

             5.2.4.3. Europe

             5.2.4.4. Asia Pacific

             5.2.4.5. Middle East

             5.2.4.6. Africa

6. North America Radiopharmaceuticals Market

         6.1. Market Size & Forecast by Value, 2020-2027

              6.1.1. By Value (USD Million)

         6.2. Market Share & Forecast

              6.2.1. By Product Type

              6.2.2. By Application

              6.2.3. By End-User

              6.2.4. By Country

                       6.2.4.1. United States

                       6.2.4.2. Canada

7. Europe Radiopharmaceuticals Market

        7.1. Market Size & Forecast by Value, 2020-2027

            7.1.1. By Value (USD Million)

            7.1.2. By Volume (Million Unit)

        7.2. Market Share & Forecast

            7.2.1. By Product Type

            7.2.2. By Application

            7.2.3. By End-User

            7.2.4. By Country

                      7.2.4.1. Germany

                      7.2.4.2. Poland

                      7.2.4.3. Russia

                      7.2.4.4. Italy

                      7.2.4.5. France

                      7.2.4.6. United Kingdom

                      7.2.4.7. Spain

                      7.2.4.8. Rest of Europe

8. Asia Pacific Radiopharmaceuticals Market

     8.1. Market Size & Forecast by Value, 2020-2027

             8.1.1. By Value (USD Million)

             8.1.2. By Volume (Million Unit)

     8.2. Market Share & Forecast

            8.2.1. By Product Type

            8.2.2. By Application

            8.2.3. By End-User

            8.2.4. By Country

                8.2.4.1. China

                8.2.4.2. India

                8.2.4.3. Japan

                8.2.4.4. Malaysia

                8.2.4.5. Singapore

                8.2.4.6. Rest of Asia Pacific

9. Latin America radiopharmaceuticals Market

    9.1. Market Size & Forecast by Value, 2020-2027

             9.1.1. By Value (USD Million)

    9.2. Market Share & Forecast

             9.2.1. By Product Type

             9.2.2. By Application

             9.2.3. By End User

             9.2.4. By Country

                 9.2.4.1. Brazil

                 9.2.4.2. Mexico

                 9.2.4.3. Rest of Latin America

10. Middle East & Africa Radiopharmaceuticals Market

    10.1. Market Size & Forecast by Value, 2020-2027

         10.1.1. By Value (USD Million)

         10.1.2. By Volume (Million Unit)

    10.2. Market Share & Forecast

         10.2.1. By Product Type

         10.2.2. By Application

         10.2.3. By End-User

         10.2.4. By Country

             10.2.4.1. Saudi Arabia

             10.2.4.2. GCC

             10.2.4.3. UAE

             10.2.4.4. South Africa

             10.2.4.5. Rest of Middle East & Africa

11. Competitive Landscape

     11.1. List of Key Players and Their Offerings

     11.2. Market/Ranking Share Analysis

     11.3. Competitive Benchmarking, By Operating Parameters

12. COVID-19 Impact

     12.1. Future Impact

     12.2. Key Developments during COVID-19

     12.3. Impact on Market

        12.3.1. Different Scenario

        12.3.2. Impact on Companies

     12.4. Regional Impact

13. Key Strategic Recommendations

14. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

14.1. Progenics Pharmaceuticals, Inc.

14.2. NorthStar Medical Radioisotopes LLC

14.3. Curium Pharma

14.4. Life Molecular Imaging

14.5. Lantheus Holdings, Inc.

14.6. Cardinal Health, Inc.

14.7. General Electric Company

14.8. Bracco S.p.A.

14.9. Bayer AG

14.10. Advanced Accelerator Applications, S.A.

14.11. Eli Lilly and Company

14.12. Nihon Medi-Physics. Co. Ltd.

14.13. FUJIFILM Toyama Chemical Co., Ltd.

14.14. Jubilant Life Sciences Ltd.

14.15. Samyoung Unitech

14.16. DuChemBio, Inc.

14.17. Other Prominent Players

 

                    

 

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.